NAS
ANIP icon

Nykredit A/S’s ANI Pharmaceuticals ANIP Stock Holding History

Nykredit A/S’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$112K Buy
+1,350
New +$108K ﹤0.01% 1275

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Nykredit A/S's ANIP Position: Q2 2026 in Review

Nykredit A/S opened a new position in ANI Pharmaceuticals (ANIP) in Q2 2026: 1,350 shares worth $112K. The stake represents ﹤0.01% of the portfolio and ranks #1275 among its holdings.

215 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Nykredit A/S held 1,350 shares of ANI Pharmaceuticals worth $112K as of Q2 2026.
  • ANI Pharmaceuticals was a new Nykredit A/S position in Q2 2026.
  • ANI Pharmaceuticals made up ﹤0.01% of Nykredit A/S's portfolio in Q2 2026, its #1275 holding.
  • 215 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.